Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2014
09/18/2014US20140275115 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
09/18/2014US20140271637 Methods of administering anti-tnfalpha antibodies
09/17/2014EP2777701A1 Composition for preventing the occurrence of a cardiovascular event in multiple risk patient comprising the ethyl ester of all-cis-5,8,11,14,17-icosapentaenoic acid
09/17/2014EP2777404A1 Use of specific carbohydrate systems during pregnancy for preventing fat accumulation in pregnant women
09/17/2014EP2777403A1 Use of specific carbohydrate systems during pregnancy for improving bone development and formation and/or for improving cognitive and cns development in offspring
09/17/2014EP2776442A1 [1, 2, 3]triazolo [4, 5 -d]pyrimidine derivatives as agonists of the cannabinoid receptor 2
09/17/2014EP2776430A1 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists
09/17/2014EP2776427A1 Modulators of atp-binding cassette transporters
09/17/2014EP2776393A1 Nampt inhibitors
09/17/2014EP2776059A2 Pharmaceutical compositions containing proteases and methods for the treatment of lysosomal storage diseases
09/17/2014EP2776050A1 Morus extracts rich in n-acids of imino sugars and or pipecolic acids
09/17/2014EP2776023A1 Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid
09/17/2014EP2776019A1 Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them
09/16/2014US8835500 Pharmaceutical formulations of amyloid inhibiting compounds
09/16/2014US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
09/16/2014US8835403 Algin oligosaccharides and the derivatives thereof as well as the manufacture and the use of the same
09/16/2014US8835378 Multi-domain amphipathic helical peptides and methods of their use
09/16/2014US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals)
09/16/2014US8834858 Treatment for dyslipidemia
09/16/2014CA2674530C Spirochromanon derivatives
09/16/2014CA2658001C Novel glucokinase activators and methods of using same
09/16/2014CA2650342C Chromium complexes
09/16/2014CA2596235C Spiroketal derivatives and use thereof as diabetic medicine
09/15/2014CA2845336A1 Encapsulated metal ion nanoclusters
09/12/2014WO2014138088A1 Bmp inhibitors and methods of use thereof
09/12/2014WO2014138016A1 Metal ion-functional fiber component complex compositions, preparation and uses thereof
09/12/2014WO2014137997A1 Exercise-regulated adipokines as therapy for diabetes management
09/12/2014WO2014137234A1 Method for fasting-diet therapy
09/12/2014WO2014137090A1 Formulation for prevention or treatment of diabetes
09/12/2014WO2014136944A1 Aqueous liquid composition including high concentration of l-histidine
09/12/2014WO2014136681A1 Water-soluble flavonoid composition; drink, food, pharmaceutical product and cosmetic product, each of which contains same; and method for producing water-soluble flavonoid composition
09/12/2014WO2014135956A1 Composition for use in the treatment of polycystic ovary syndrome
09/12/2014WO2014135840A1 Nanoparticle peptide compositions
09/12/2014WO2014134833A1 Edible composition, preparation method therefor, and food product comprising the composition
09/11/2014US20140256743 Cathepsin cysteine protease inhibitors
09/11/2014US20140256652 Polypeptides Involved In Immune Response
09/11/2014US20140256632 Methods useful in the treatment of bone resorption diseases
09/10/2014EP2774917A1 Pharmaceutical composition for treating diabetes
09/10/2014EP2774620A1 Method for modulating weight loss
09/10/2014EP2774619A1 Composition for the treatment of hyperglycaemic diseases
09/10/2014EP2774616A1 Application of roseburia in treating and preventing obesity related diseases
09/10/2014EP2774609A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor
09/10/2014EP2773645A1 Imidazopyridazine compounds
09/10/2014EP2773619A1 New aryl-quinoline derivatives
09/10/2014EP2773377A1 Glp-1 receptor agonist peptide gastrin conjugates
09/10/2014EP2773365A1 Peptide analogs for treating diseases and disorders
09/10/2014EP2773363A1 Nutritional supplement for weight management
09/09/2014US8828991 Azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
09/09/2014US8828973 Compounds as receptor modulators with therapeutic utility
09/09/2014US8828935 Agent for suppressing elevation of blood triglyceride concentration
09/09/2014US8828934 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
09/09/2014US8828359 Particulate materials
09/09/2014CA2693154C Insulinotropic peptide derivative wherein its n-terminal amino acid is modified
09/09/2014CA2655317C Ruminant feed supplement containing rice bran to avoid milk fever
09/09/2014CA2617282C Novel imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
09/09/2014CA2477854C Compositions and methods for treatment of body weight conditions with milk minerals and casein fractions
09/04/2014WO2014134477A1 Methods and systems for treating overweight individuals
09/04/2014WO2014134053A1 Ascorbate esters of omega-3 fatty acids
09/04/2014WO2014133361A1 Tricyclic compound and use thereof
09/04/2014WO2014132134A1 A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
09/04/2014WO2014087006A8 Method and device for administering hypoxic and hyperoxic gas
09/04/2014WO2014013505A8 Amorphous vildagliptin
09/04/2014WO2013109342A8 Method of treating diabetes using non-glycosylated apolipoprotein a-iv
09/04/2014US20140248700 Method of Differentiation of Morula or Inner Cell Mass Cells and Method of Making Lineage-Defective Embryonic Stem Cells
09/04/2014US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
09/03/2014EP2772485A1 Bicyclic compound
09/03/2014EP2772484A1 Bicyclic heterocyclic compound
09/03/2014EP2772256A1 Compositions for retarding weight gain associated with use of atypical antipsychotic drugs
09/03/2014EP2771313A1 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes
09/03/2014EP2771024A1 Treatment protocol of diabetes type 2
09/03/2014EP2771023A1 Oral formulations mimetic of roux-en-y gastric bypass actions on the ileal brake; compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and t2d
09/03/2014EP2770991A1 Orally-administered plastid expressed cholera toxin b subunit-exendin 4 as treatment for type 2 diabetes
09/03/2014EP2770986A1 Apparatus and method for producing controlled dosage of bioactive agent
09/03/2014EP2770984A1 Device and method for sustained release of therapeutic agent
09/02/2014US8822519 Compound with agitation effect on peroxisome proliferator-activated receptor process for its preparation and use thereof
09/02/2014US8822480 Bicyclic heterocycle derivatives and use thereof as GPR119 modulators
09/02/2014US8822473 Method of treating diabetes
09/02/2014US8822449 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
09/02/2014US8822447 Indazole compounds useful as ketohexokinase inhibitors
09/02/2014US8822411 Truncated activin type II receptor and methods of use
09/02/2014US8822169 HMG1 antibody for treating inflammatory conditions
08/2014
08/28/2014WO2014131008A1 A polipoprotein c3 (apociii) antagonists and methods of their use to remove apociii inhibition of lipoprotein lipase (lpl)
08/28/2014WO2014130965A1 Gastrokine-1 (gkn1) binding proteins and methods of treatment
08/28/2014WO2014129969A1 Therapeutic agents
08/28/2014WO2014128639A1 Composition for the treatment of metabolic disorders
08/28/2014WO2014128549A1 Novel ampk activator
08/28/2014WO2014128257A1 Serpins: methods of therapeutic beta-cell regeneration and function
08/28/2014WO2014128209A1 Pharmaceutical formulation comprising dpp-iv inhibitor agglomerates
08/28/2014WO2014128116A1 A production process for gliclazide formulations
08/28/2014WO2014107531A3 Desensitizing drug products containing lidocaine, thymol and ethanol
08/28/2014WO2014093696A3 Insulin derivatives for diabetes treatment
08/28/2014WO2013138568A8 Liver x receptor modulators
08/28/2014US20140242089 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
08/27/2014EP2769978A1 saxagliptin derivatives
08/27/2014EP2769976A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof
08/27/2014EP2769974A1 Novel AMPK activator
08/27/2014EP2769732A1 Serpins: methods of therapeutic beta-cell regeneration and function
08/27/2014EP2769715A2 Methods for treating autoimmune disorders, and reagents related thereto
08/27/2014EP2769712A1 Pharmaceutical formulation comprising DPP-IV inhibitor agglomerates and DPP-IV inhibitor particles
08/27/2014EP2768832A1 Novel substituted imidazopyrimidines as gpbar1 receptor modulators
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 1298